Small‐Bowel Adaptation: A Case of Morphological Changes Induced by Teduglutide in Short‐Bowel Syndrome With Intestinal Failure

Teduglutide (TED) reduces the need for parenteral support (PS) in patients with short‐bowel syndrome with intestinal failure (SBS‐IF). It is a glucagon‐like peptide‐2 analog that improves absorption, induces the expansion of the absorptive epithelium in the small intestine, and may be used in patients with SBS‐IF after a 6‐ to 12‐month adaptation period, if PS is always necessary. We described the functional and morphological effect of TED in a...